TrialPloS one2017

Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study.

Qian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.